Skip to main content
logo
Coeptis Therapeutics Holdings, Inc. (COEP)
Apr 24, 2026 - COEP merged into ZSQR
16.40
+0.19 (1.17%)
Inactive · Last trade price on Apr 24, 2026

COEP Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.361.36---0.08
Revenue Growth
------
Gross Profit
1.231.18---0.08
Operating Income
-13.04-13.04-10.05-21.49-34.2-14.05
Net Income
-10.91-11.92-10.68-21.27-37.57-13.45
Earnings Per Share
-2.98-2.81-5.56-16.56-2.63-24.60
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.356.350.531.473.792.18
Total Debt
0.270.271.41.222.064.08
Net Cash (Debt)
6.086.08-0.870.241.73-1.9
Net Cash Growth
----85.88%--
Net Cash Per Share
1.441.44-0.450.191.35-3.49

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.6-8.6-6.65-7.24-3.88-4.49
Free Cash Flow
-8.6-8.6-6.65-7.24-3.88-4.49
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
90.06%86.75%---100.00%
Operating Margin
-956.94%-956.94%----18727.90%
Pretax Margin
-900.72%-900.72%----17932.40%
Profit Margin
-900.72%-900.72%----17932.40%
FCF Margin
-631.16%-631.16%----5985.92%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
74.8860.08---1250.00